Cargando…
Transcriptome signature analysis repurposes trifluoperazine for the treatment of fragile X syndrome in mouse model
Fragile X syndrome (FXS) is a prevailing genetic disorder of intellectual disability and autism. There is no efficacious medication for FXS. Through in silico screening with a public database, computational analysis of transcriptome profile in FXS mouse neurons predicts therapeutic value of an FDA-a...
Autores principales: | Ding, Qi, Sethna, Ferzin, Wu, Xue-Ting, Miao, Zhuang, Chen, Ping, Zhang, Yueqi, Xiao, Hua, Feng, Wei, Feng, Yue, Li, Xuan, Wang, Hongbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075969/ https://www.ncbi.nlm.nih.gov/pubmed/32179850 http://dx.doi.org/10.1038/s42003-020-0833-4 |
Ejemplares similares
-
Pharmacological enhancement of mGluR5 facilitates contextual fear memory extinction
por: Sethna, Ferzin, et al.
Publicado: (2014) -
Enhanced expression of ADCY1 underlies aberrant neuronal signalling and behaviour in a syndromic autism model
por: Sethna, Ferzin, et al.
Publicado: (2017) -
Carbamazepine Restores Neuronal Signaling, Protein Synthesis, and Cognitive Function in a Mouse Model of Fragile X Syndrome
por: Ding, Qi, et al.
Publicado: (2020) -
Trifluoperazine-Induced Angioedema
por: Osman, Mugtaba, et al.
Publicado: (2014) -
Vorinostat Corrects Cognitive and Non-Cognitive Symptoms in a Mouse Model of Fragile X Syndrome
por: Ding, Qi, et al.
Publicado: (2021)